Post-operative immunotherapy helps people with high-risk bladder cancer live longer without cancer, clinical trial finds
Adjuvant pembrolizumab helps people with muscle-invasive bladder cancer stay cancer-free longer than with observation alone. Credit: National Cancer Institute Results ...